Notably, a robust two- gene classifier composed of OBSCN and PRUNE2 was found to differentiate between gastrointestinal stromal tumor (GIST) and leiomyosarcoma (LMS) with near-perfect accuracy in close to 100 patients tested [26]. This evidence concerns the gene PRUNE2 and gastrointestinal stromal tumor.